Extended Data Fig. 4: Spider plot of clinical responses.
From: Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Changes in tumor size over time after CT041 infusion in the 36 patients with measurable target lesions. Solid lines indicate patients who achieved a best response of partial response or better; dashed lines indicate patients who achieved a best response of stable disease or progressive disease.
